Hydroxycarbamide - Polycythaemia, Thrombocythaemia and Myelofibrosis
You are here : Home > Formulary Search > Hydroxycarbamide - Polycythaemia, Thrombocythaemia and Myelofibrosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
PAD Profile
ChemicalSubstance :
Hydroxycarbamide
Indication :
Polycythaemia, Thrombocythaemia and Myelofibrosis
Group Name :
Keywords :
Brand Names Include :
Hydrea
Important Information :
Initiation and 3 months of treatment to be provided by specilaist team before any requests for primary care prescribing.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Committee Recommendations (1)
The PCN reviewed and agreed the updated Blue information sheet below which will be taken through internal governance processes a the provider trusts for agreement
Other Indications
Below are listed other indications that Hydroxycarbamide is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Polycythaemia, Thrombocythaemia and Myelofibrosis.
- No records returned.